Converge Bio
The Generative AI Lab for the Life Sciences
Tel Aviv, Israel · Founded 2024 · $30.5M raised
- Headquarters
- Tel Aviv
- Employees
- 11–50
- Founded
- 2024
- Business Model
- B2B
- Website
- converge-bio.com
- Total Funding
- $30.5M
- Last Round
- $25.0M Series AJan 2025
- Rounds
- 2
About
Converge Bio is an AI-driven drug discovery company founded in 2024 and headquartered in Tel Aviv, Israel with a presence in Boston, Massachusetts. The company provides a generative AI lab for life sciences, helping pharmaceutical and biotech customers accelerate drug development through AI-powered molecule design, discovery, and manufacturing optimization. Founded by CEO Dov Gertz, CTO Oded Kalev, and CSO Iddo Weiner, Converge Bio raised a $5.5M seed in 2024 and a $25M Series A in January 2026 led by Bessemer Venture Partners. The company has completed over 40 programs with more than a dozen pharma and biotech clients globally.
Summary
Converge Bio is an Artificial Intelligence company based in Tel Aviv, Israel, founded in 2024. It has raised $30.5M in total across 2 rounds, most recently a $25.0M Series A round in Jan 2025. Investors include TLV Partners.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2025
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/converge-bio"><img src="https://indexed.vc/api/badge/company/converge-bio" alt="Converge Bio on Indexed.vc" width="260" height="76" /></a>